Kyowa Kirin

Performance

About Kyowa Kirin

Kyowa Kirin is a Japan-based global specialty pharmaceutical company focused on developing antibody-based therapies and life-science innovations to treat cancer, kidney diseases, immune system disorders, and rare diseases. The group emphasizes research and development across bone and mineral diseases, hematologic malignancies, and hematopoietic stem cell gene therapy, with a global network spanning Asia-Pacific, North America, and Europe. Its mission centers on delivering life-changing value through diverse drug discovery technologies and partnerships while prioritizing patient care and global health outcomes.